CXCR4 and cancer: Furthermore, small molecular compounds, peptide antagonists, and specific antibodies against CXCR4 can efficiently inhibit downstream signaling of CXCL12/CXCR4 axis, block cancer dissemination and improve the outcome of patients 12, 15, 16.